Fig. 1From: Clinical outcomes up to 9 years after [18F]flutemetamol amyloid-PET in a symptomatic memory clinic populationFlow diagram of study design and patient selectionIn the panel on the left (gray), the study design of the original clinical study is described [5]. In the panels on the right, the selection (green) and exclusion (orange) process of the current longitudinal study is shownBack to article page